DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Conroy T, Hammel P, Hebbar M.
Unicancer GI PRODIGE 24/CCTG PA.6 trial: A multicenter international randomized phase III trial of adjuvant mFOLFIRINOX versus gemcitabine (gem) in patients with resected pancreatic ductal adenocarcinomas.
J Clin Oncol 2018;
36: 18_suppl-LBA4001
We do not assume any responsibility for the contents of the web pages of other providers.